496 related articles for article (PubMed ID: 30095672)
41. Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness.
Knowles SR; Austin DW; Sivanesan S; Tye-Din J; Leung C; Wilson J; Castle D; Kamm MA; Macrae F; Hebbard G
Psychol Health Med; 2017 Jun; 22(5):524-534. PubMed ID: 27045996
[TBL] [Abstract][Full Text] [Related]
42. Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules.
Guo Q; Lin H; Chen P; Tan S; Wen Z; Lin L; He J; Wen J; Lu S
Bioengineered; 2021 Dec; 12(2):11885-11897. PubMed ID: 34923901
[TBL] [Abstract][Full Text] [Related]
43. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
[TBL] [Abstract][Full Text] [Related]
44. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.
Ahluwalia B; Iribarren C; Magnusson MK; Sundin J; Clevers E; Savolainen O; Ross AB; Törnblom H; Simrén M; Öhman L
Cells; 2021 Jun; 10(6):. PubMed ID: 34200772
[TBL] [Abstract][Full Text] [Related]
45. Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
Midenfjord I; Borg A; Törnblom H; Simrén M
Am J Gastroenterol; 2021 Apr; 116(4):769-779. PubMed ID: 33982947
[TBL] [Abstract][Full Text] [Related]
46. Does symptom activity explain psychological differences in patients with irritable bowel syndrome and inflammatory bowel disease? Results from a multi-center cross-sectional study.
Berens S; Schaefert R; Baumeister D; Gauss A; Eich W; Tesarz J
J Psychosom Res; 2019 Nov; 126():109836. PubMed ID: 31627144
[TBL] [Abstract][Full Text] [Related]
47. A Microbial Relationship Between Irritable Bowel Syndrome and Depressive Symptoms.
Perez NB; Wright F; Vorderstrasse A
Biol Res Nurs; 2021 Jan; 23(1):50-64. PubMed ID: 32705884
[TBL] [Abstract][Full Text] [Related]
48. Of bowels, brain and behavior: A role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome.
Wilmes L; Collins JM; O'Riordan KJ; O'Mahony SM; Cryan JF; Clarke G
Neurogastroenterol Motil; 2021 Mar; 33(3):e14095. PubMed ID: 33580895
[TBL] [Abstract][Full Text] [Related]
49. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
[TBL] [Abstract][Full Text] [Related]
50. Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities.
Kibune Nagasako C; Garcia Montes C; Silva Lorena SL; Mesquita MA
Rev Esp Enferm Dig; 2016 Feb; 108(2):59-64. PubMed ID: 26838486
[TBL] [Abstract][Full Text] [Related]
51. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
[TBL] [Abstract][Full Text] [Related]
52. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.
Jeffery IB; O'Toole PW; Öhman L; Claesson MJ; Deane J; Quigley EM; Simrén M
Gut; 2012 Jul; 61(7):997-1006. PubMed ID: 22180058
[TBL] [Abstract][Full Text] [Related]
53. Impact of auricular percutaneous electrical nerve field stimulation on gut microbiome in adolescents with irritable bowel syndrome: A pilot study.
Bora G; Atkinson SN; Pan A; Sood M; Salzman N; Karrento K
J Dig Dis; 2023 May; 24(5):348-358. PubMed ID: 37448237
[TBL] [Abstract][Full Text] [Related]
54. Influence of psychological distress on characteristics of symptoms in patients with GERD: the role of IBS comorbidity.
Rey E; García-Alonso M; Moreno-Ortega M; Almansa C; Alvarez-Sanchez A; Díaz-Rubio M
Dig Dis Sci; 2009 Feb; 54(2):321-7. PubMed ID: 18649139
[TBL] [Abstract][Full Text] [Related]
55. Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.
Choo C; Mahurkar-Joshi S; Dong TS; Lenhart A; Lagishetty V; Jacobs JP; Labus JS; Jaffe N; Mayer EA; Chang L
Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G134-G143. PubMed ID: 35726867
[TBL] [Abstract][Full Text] [Related]
56. Integrative analysis of the gut microbiome and metabolome in a rat model with stress induced irritable bowel syndrome.
Hu Y; Chen F; Ye H; Lu B
Sci Rep; 2021 Sep; 11(1):17596. PubMed ID: 34475489
[TBL] [Abstract][Full Text] [Related]
57. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
[TBL] [Abstract][Full Text] [Related]
58. Saccharomyces boulardii CNCM I-745 modulates the microbiota-gut-brain axis in a humanized mouse model of Irritable Bowel Syndrome.
Constante M; De Palma G; Lu J; Jury J; Rondeau L; Caminero A; Collins SM; Verdu EF; Bercik P
Neurogastroenterol Motil; 2021 Mar; 33(3):e13985. PubMed ID: 32955166
[TBL] [Abstract][Full Text] [Related]
59. The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome.
Yao X; Yang Y; Zhang S; Shi Y; Zhang Q; Wang Y
BMC Gastroenterol; 2020 Jul; 20(1):209. PubMed ID: 32631285
[TBL] [Abstract][Full Text] [Related]
60. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
